<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ASimple_agreement_for_future_equity_%28SAFE%29</id>
	<title>Definition:Simple agreement for future equity (SAFE) - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ASimple_agreement_for_future_equity_%28SAFE%29"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Simple_agreement_for_future_equity_(SAFE)&amp;action=history"/>
	<updated>2026-06-14T15:29:09Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Simple_agreement_for_future_equity_(SAFE)&amp;diff=17053&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Simple_agreement_for_future_equity_(SAFE)&amp;diff=17053&amp;oldid=prev"/>
		<updated>2026-03-15T10:09:05Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;📄 &amp;#039;&amp;#039;&amp;#039;Simple agreement for future equity (SAFE)&amp;#039;&amp;#039;&amp;#039; is a financing instrument frequently used by early-stage [[Definition:Insurtech | insurtech]] startups to raise capital without immediately setting a fixed [[Definition:Pre-money valuation | valuation]] or issuing equity, instead granting investors the right to convert their investment into shares at a future [[Definition:Equity financing | equity financing]] round — typically a [[Definition:Series A funding | Series A]] or [[Definition:Series B funding | Series B]]. Originated by Y Combinator in 2013, the SAFE has become a staple of startup fundraising globally and is particularly prevalent among insurance technology ventures where founders need rapid, lightweight funding to build a minimum viable product, secure initial [[Definition:Binding authority agreement | carrier partnerships]], or develop proprietary [[Definition:Data analytics | data models]] before the business has enough operating history to support a traditional priced round.&lt;br /&gt;
&lt;br /&gt;
⚙️ A SAFE is not debt — it carries no interest rate, no maturity date, and no repayment obligation. Instead, it converts into [[Definition:Preferred stock | preferred equity]] when a qualifying financing event occurs, at terms governed by parameters negotiated upfront: most commonly a valuation cap (the maximum [[Definition:Post-money valuation | post-money valuation]] at which the SAFE converts, protecting early investors from excessive dilution) and sometimes a discount rate (giving the SAFE holder a percentage reduction on the price per share paid by later investors). For an insurtech [[Definition:Managing general agent (MGA) | MGA]] or a [[Definition:Claims management | claims]]-tech startup raising a few hundred thousand to a few million dollars in its earliest days, SAFEs offer speed and simplicity — there is no complex term sheet negotiation, no board seats at stake, and minimal legal cost compared to a priced [[Definition:Seed funding | seed round]]. However, because multiple SAFEs with different caps can stack up, founders must carefully model the [[Definition:Dilution | dilutive]] impact that emerges when they all convert simultaneously at the next priced round.&lt;br /&gt;
&lt;br /&gt;
💡 For insurance industry participants evaluating or investing in early-stage ventures — whether they are [[Definition:Insurance carrier | carrier]] innovation labs, corporate [[Definition:Venture capital | venture]] arms, or [[Definition:Angel investor | angel investors]] with insurance backgrounds — understanding SAFEs is essential. The instrument&amp;#039;s simplicity can mask real economic consequences: a low valuation cap on a SAFE effectively sets a ceiling on the company&amp;#039;s value from the investor&amp;#039;s perspective, and excessive SAFE issuance before a priced round can create a &amp;quot;stacked cap table&amp;quot; that discourages institutional investors from participating later. In the insurtech world, where ventures may need extended runway to navigate [[Definition:Insurance license | licensing]] requirements, build [[Definition:Actuarial science | actuarial]] credibility, and prove out [[Definition:Loss ratio | loss ratios]], SAFEs provide a pragmatic bridge — but both founders and investors benefit from clear modeling of conversion scenarios well before the next fundraising milestone.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Convertible note]]&lt;br /&gt;
* [[Definition:Pre-money valuation]]&lt;br /&gt;
* [[Definition:Post-money valuation]]&lt;br /&gt;
* [[Definition:Seed funding]]&lt;br /&gt;
* [[Definition:Venture capital]]&lt;br /&gt;
* [[Definition:Dilution]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>